106 related articles for article (PubMed ID: 16985165)
1. PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease.
Goodin GS; Shulkin BL; Kaufman RA; McCarville MB
AJR Am J Roentgenol; 2006 Oct; 187(4):1124-8. PubMed ID: 16985165
[TBL] [Abstract][Full Text] [Related]
2. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.
Metser U; Miller E; Lerman H; Even-Sapir E
AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662
[TBL] [Abstract][Full Text] [Related]
3. The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT.
Strobel K; Exner UE; Stumpe KD; Hany TF; Bode B; Mende K; Veit-Haibach P; von Schulthess GK; Hodler J
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2000-8. PubMed ID: 18712385
[TBL] [Abstract][Full Text] [Related]
4. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
Rosen RS; Fayad L; Wahl RL
J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
[TBL] [Abstract][Full Text] [Related]
5. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
von Falck C; Rosenthal H; Gratz KF; Galanski M
Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
[TBL] [Abstract][Full Text] [Related]
6. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
7. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.
Nakamoto Y; Cohade C; Tatsumi M; Hammoud D; Wahl RL
Radiology; 2005 Nov; 237(2):627-34. PubMed ID: 16244271
[TBL] [Abstract][Full Text] [Related]
8. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
Cho WI; Chang UK
J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
[TBL] [Abstract][Full Text] [Related]
10. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
11. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
12. Oncologic significance of unexpected osseous foci on FDG-PET without correlative CT abnormalities.
Zamora E; Valdivia AY
Ann Nucl Med; 2021 Mar; 35(3):347-359. PubMed ID: 33439440
[TBL] [Abstract][Full Text] [Related]
13. Detection of bone metastases: assessment of integrated FDG PET/CT imaging.
Taira AV; Herfkens RJ; Gambhir SS; Quon A
Radiology; 2007 Apr; 243(1):204-11. PubMed ID: 17392254
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
15. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
16. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management.
Basu S; Nair N; Banavali S
Br J Radiol; 2007 Sep; 80(957):750-6. PubMed ID: 17709361
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
[TBL] [Abstract][Full Text] [Related]
18. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
19. Fibrous lesions in the lower extremities in neurofibromatosis.
Mandell GA; Dalinka MK; Coleman BG
AJR Am J Roentgenol; 1979 Dec; 133(6):1135-8. PubMed ID: 116506
[TBL] [Abstract][Full Text] [Related]
20. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]